Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs.

Nat Rev Cardiol · 2019 · PMC7136162 · PMID 30250166

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantP = 0.06so close (0.05 < p ≤ 0.1)

Finally, a borderline significant ( P = 0.06) 0.9% absolute reduction in the primary cardiovascular outcome measure was found with exenatide in the EXCEL study 174 .

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.